The FDA issued a new requirement that stronger warning labels be included on extended-release opioid painkillers, such as:
- Vicodin;
- OxyContin; and
- morphine.
Overdose injuries and deaths from painkillers...
FDA Requires Label Changes on Fluoroquinolone Drugs/Serious Risk
The U.S. Food and Drug Administration (FDA) is requiring the drug labels and Medication Guides for all fluoroquinolone antibacterial drugs to be updated, and to inform consumers of the serious side effects of peripheral neuropathy. This is a type...
FDA Reviews Psychiatric Side Effects of Chantrix
The U.S. Food and Drug Administration (FDA) announced Friday it will convene a public meeting in October to review the risks of psychiatric and behavioral side effects with Pfizer’s anti-smoking drug Chantrix.
The FDA said in a federal notice...